# Artesunate Ointment for the Treatment of Anal HSIL in HIV-negative Participants

> **NCT06206564** · PHASE2 · RECRUITING · sponsor: **Frantz Viral Therapeutics, LLC** · enrollment: 48 (estimated)

## Conditions studied

- Anal High-grade Squamous Intraepithelial Lesion
- Anal HSIL
- Anal HPV Infection
- AIN

## Interventions

- **DRUG:** Artesunate ointment
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06206564
- **Lead sponsor:** Frantz Viral Therapeutics, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-12
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2025-05-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06206564

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06206564, "Artesunate Ointment for the Treatment of Anal HSIL in HIV-negative Participants". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06206564. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*